Aviva Portfolio holdings
AUM
$48.4B
1-Year Return
24.25%
This Quarter Return
+22.94%
1 Year Return
+24.25%
3 Year Return
+97.85%
5 Year Return
+166.96%
10 Year Return
+393.57%
AUM
$16B
AUM Growth
+$2.39B
(+18%)
Cap. Flow
-$410M
Cap. Flow
% of AUM
-2.55%
Top 10 Holdings %
Top 10 Hldgs %
24.43%
Holding
979
New
49
Increased
147
Reduced
723
Closed
36
Top Buys
| 1 |
Union Pacific
UNP
|
+$107M |
| 2 |
Alcon
ALC
|
+$88.1M |
| 3 |
Otis Worldwide
OTIS
|
+$75.5M |
| 4 |
Marsh & McLennan
MMC
|
+$53M |
| 5 |
Merck
MRK
|
+$48.8M |
Top Sells
| 1 |
RTN
Raytheon Company
RTN
|
+$56M |
| 2 |
Amazon
AMZN
|
+$44.3M |
| 3 |
JPMorgan Chase
JPM
|
+$42.3M |
| 4 |
AGN
Allergan plc
AGN
|
+$36.5M |
| 5 |
Microsoft
MSFT
|
+$32.6M |
Sector Composition
| 1 | Technology | 22.31% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 13.68% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Vail Resorts
MTN
$5.37B
| $2.46M | 0.02% |
13,513
-592
| -4% | -$108K |
|
577
BorgWarner
BWA
$9.34B
| $2.45M | 0.02% |
78,787
-3,659
| -4% | -$114K |
|
578
QuidelOrtho
QDEL
$1.88B
| $2.43M | 0.02% |
10,854
-27,297
| -72% | -$6.11M |
|
|
EIDX
579
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $2.43M | 0.02% |
50,899
-22,207
| -30% | -$1.06M |
|
|
PRNB
580
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $2.43M | 0.02% |
40,581
-28,200
| -41% | -$1.69M |
|
581
Perrigo
PRGO
$3.04B
| $2.43M | 0.02% |
43,870
-490
| -1% | -$27.1K |
|
|
SJR
582
DELISTED
Shaw Communications Inc.
SJR
| $2.42M | 0.02% |
149,274
-9,011
| -6% | -$146K |
|
583
Veracyte
VCYT
$2.42B
| $2.42M | 0.02% |
93,409
-66,746
| -42% | -$1.73M |
|
|
WRK
584
DELISTED
WestRock Company
WRK
| $2.42M | 0.02% |
85,488
-3,796
| -4% | -$107K |
|
585
10x Genomics
TXG
$1.57B
| $2.41M | 0.02% |
+26,979
| New | +$2.41M |
|
586
Lincoln National
LNC
$7.88B
| $2.41M | 0.02% |
65,362
-4,361
| -6% | -$160K |
|
|
VVNT
587
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $2.41M | 0.02% |
+138,752
| New | +$2.41M |
|
588
AGNC Investment
AGNC
$10.7B
| $2.4M | 0.02% |
186,025
-4,145
| -2% | -$53.5K |
|
|
LVGO
589
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $2.4M | 0.02% |
+31,916
| New | +$2.4M |
|
590
Coca-Cola Europacific Partners
CCEP
$40.4B
| $2.39M | 0.01% |
63,256
+1,498
| +2% | +$56.6K |
|
591
CryoPort
CYRX
$480M
| $2.39M | 0.01% |
78,944
-149,615
| -65% | -$4.53M |
|
592
Bio-Rad Laboratories Class A
BIO
$7.49B
| $2.39M | 0.01% |
5,282
-5,534
| -51% | -$2.5M |
|
593
Exelixis
EXEL
$10.1B
| $2.39M | 0.01% |
100,478
-110,340
| -52% | -$2.62M |
|
594
NovaGold Resources
NG
$2.69B
| $2.38M | 0.01% |
259,234
-199,976
| -44% | -$1.84M |
|
595
Bio-Techne
TECH
$7.93B
| $2.38M | 0.01% |
35,988
-43,040
| -54% | -$2.84M |
|
596
Insulet
PODD
$23.8B
| $2.37M | 0.01% |
12,214
-8,679
| -42% | -$1.69M |
|
597
Zscaler
ZS
$43.4B
| $2.37M | 0.01% |
21,672
-39,956
| -65% | -$4.38M |
|
598
Datadog
DDOG
$48.5B
| $2.37M | 0.01% |
+27,279
| New | +$2.37M |
|
599
Halozyme
HALO
$8.87B
| $2.37M | 0.01% |
88,453
-114,004
| -56% | -$3.06M |
|
600
Masimo
MASI
$7.92B
| $2.37M | 0.01% |
10,394
-9,846
| -49% | -$2.25M |
|